Status:
UNKNOWN
The QUILT Study: Quilting Sutures in Patients Undergoing Breast Cancer Surgery
Lead Sponsor:
Canisius-Wilhelmina Hospital
Collaborating Sponsors:
Rijnstate Hospital
OLVG
Conditions:
Seroma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Seroma is the most common complication following breast cancer surgery, with reported incidence up to 90%. Seroma causes patient discomfort, is associated with surgical site infections (SSI), often re...
Detailed Description
Seroma is the most common complication following breast cancer surgery, with reported incidence up to 90%. Seroma causes patient discomfort, is associated with surgical site infections (SSI), often re...
Eligibility Criteria
Inclusion
- all patients \>18 years of age undergoing mastectomy and/or axillary lymph node dissection
- be irrespective of the nature of the primary tumour: prophylactic, risk reducing, benign, in situ carcinoma and invasive primary or recurrent carcinoma will be eligible, irrespective of preoperative systemic therapy.
Exclusion
- patients who objected to participation (letter of objection)
- mentally incompetent patients or otherwise unable to complete a questionnaire
- immediate breast reconstruction
- pregnancy
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT05272904
Start Date
August 1 2022
End Date
July 1 2023
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Canisius Wilhelmina Hospital
Nijmegen, Gelderland, Netherlands, 6532 SZ